Federal health regulators will take more time to review a highly-contested drug for muscular dystrophy that has become a flashpoint in the debate over patient access to experimental medicine. … Click to Continue »
Living articles about food home & travel from in Kansas City, MO | KansasCity.com &, Kansas City Star: Living
Wed, 05/25/2016 - 9:29am
Federal health regulators will take more time to review a highly-contested drug for muscular dystrophy that has become a flashpoint in the debate over patient access to experimental medicine. … Click to Continue »